Navigation Links
Bayer HealthCare to Sponsor World Federation of Hemophilia Global Training Program and Donate Kogenate® FS, Antihemophilic Factor (Recombinant), Commercially Valued At More Than $7 Million
Date:4/28/2011

ips have been awarded to hematologists, nurses, physiotherapists, laboratory scientists, orthopedic surgeons and dentists.  Since the program's founding, 400 fellows from 80 countries have received training.  Of note, more than 70% of fellows who have received training continue their career in hemophilia care.  

"More than 40 years after its founding, the IHTC program continues to improve the education of health care professionals who are dedicated to treating people with hemophilia," said Hansjoerg Duerr, Ph.D., Vice President, Specialty Medicine, Bayer HealthCare Pharmaceuticals.  "It is Bayer's privilege to sponsor an initiative of such great importance and also to make such a significant donation of Kogenate FS."

About Hemophilia A

Hemophilia A, also known as factor VIII deficiency or classic hemophilia, is largely an inherited bleeding disorder in which one of the proteins needed to form blood clots in the body is missing or reduced. Hemophilia A is the most common type of hemophilia and is characterized by prolonged or spontaneous bleeding, especially into the muscles, joints, or internal organs. Approximately 400,000 people around the world have hemophilia.

About Kogenate® FS/KOGENATE® Bayer

Indications and Usage

Kogenate® FS, antihemophilic factor (recombinant) /KOGENATE® Bayer (recombinant coagulation Factor VIII [octocog alfa]) is a recombinant factor VIII treatment indicated for the control and prevention of bleeding episodes and perioperative management in adults and children (0-16 years) with hemophilia A. Kogenate® FS/KOGENATE® Bayer is also indicated for routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children with hemophilia A with no preexisting joint damage.

Important Safety Information

The most serious adverse reactions are systemic hypersensitivity reactions and th
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014   Assurex Health, a personalized medicine ... providers for behavioral health and chronic pain conditions, ... in equity financing from new and existing investors, ... and Chief Executive Officer. The financing ... Assurex Health,s GeneSight ®  products.  GeneSight,s ...
(Date:12/24/2014)... 23, 2014  The American Diabetes Association is ... for people with diabetes and that all people ... of statins, in keeping with recent changes to ... American College of Cardiology (ACC) and American Heart ... most recent changes to the Association,s annual revised ...
(Date:12/24/2014)... 23, 2014 In response to urgent requests from the ... Sierra Leone , Direct Relief delivered two 10-bed ... the treatment of local health workers who contract Ebola while ... Ebola care center was constructed for foreign health care workers ... available for local Sierra Leonean health workers. With ...
Breaking Medicine Technology:Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2
... , June 16 TechniScan, (OTC Bulletin Board: TSNI) a ... 3D breast ultrasound imaging system, today announced that it has launched a ... to commence in the last five months. , ... TechniScan,s Warm Bath Ultrasound (WBU) system is designed to ...
... Concerned About Drugs, Role in Crisis of Prematurity , ... WHITE PLAINS, N.Y. , June 16 The widespread use of fertility ...  contributes to the problem of premature birth in the United States , experts said ... , , ...
Cached Medicine Technology:TechniScan Announces Adding Another Center to Worldwide Clinical Trials for New Breast Imaging System 2TechniScan Announces Adding Another Center to Worldwide Clinical Trials for New Breast Imaging System 3TechniScan Announces Adding Another Center to Worldwide Clinical Trials for New Breast Imaging System 4TechniScan Announces Adding Another Center to Worldwide Clinical Trials for New Breast Imaging System 5Fertility Drugs Contribute Heavily to Multiple Births 2Fertility Drugs Contribute Heavily to Multiple Births 3
(Date:12/26/2014)... December 26, 2014 Cooking and ... 3.1 out of 5. This score reflects slightly positive ... of product specialization, low switching costs and a low ... by the low availability of substitutes for cooking and ... of steel and aluminum, key inputs in the production ...
(Date:12/26/2014)... “Many people become overwhelmed by the thought ... and phone calls with insurance companies,” The Jones Firm ... free eBook on pedestrian and bicycle accidents . ... bicycle auto accident claims assures the injured individual that ... handling their case while they focus on recovering. ...
(Date:12/26/2014)... Parker & Sons, Inc. a reliable ... cooling and plumbing contractor services throughout Arizona announces ... 2014 with regard to air-conditioning systems. Residential and ... for its incredibly hot summers. Working with an ... details of a wide variety of systems made ...
(Date:12/25/2014)... 2014 The report “Nintedanib (Colorectal ... focuses on the current treatment landscape, unmet needs, ... cancer market. Stivarga is a drug which is ... cancer. Boehringer Ingelheim is developing nintedanib (BIBF-1120), an ... refractory CRC in the US, Europe, and Japan. ...
(Date:12/25/2014)... iFitDress.com, the popular online supplier of wedding dresses and special ... black one-shoulder cocktail dresses . In addition, all these ... discounted prices, up to 70% off. , The ... only. You know, we have thousands of frequent callers in ... items can visit our website for more details. The current ...
Breaking Medicine News(10 mins):Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2
... ... Sidney Funk, a board certified OB-GYN with over 35 years experience, has joined the executive ... ... Funk, a board certified OB-GYN with over 35 years experience, has joined the executive team ...
... appears to effectively deliver genetic material into cells with minimal ... that this device, a vector, is able to deliver DNA ... be activated a critical step in gene therapy. This ... than other experimental materials, according to the research. Biomedical ...
... It is well-documented that when negotiating winding roads, drivers ... lane marking referred to as the tangent point. New ... in left-hand curves, wide curves and when leaving a curve, ... Alternatively, when drivers enter or maneuver through a ...
... used to prevent potentially dangerous blood clots in recovering ... acute medical illness, doctors have found in a multi-institutional ... and patients strictly confined to 24-hour bed rest, a ... reduced the chances of blood clots while only slightly ...
... Amanda Gardner HealthDay Reporter , TUESDAY, July 6 ... shorter telomeres may be at a higher risk of developing ... new research suggests. Telomeres are the "shoelace ends" that ... you age. Right now, the findings aren,t likely ...
... ... entire Diamond Dreams Collection. Full of Diamond Tennis Bracelets with the most exquisite design and ... ... completion of the entire Diamond Dreams Collection. Full of Diamond Tennis Bracelets with the most ...
Cached Medicine News:Health News:Jackson Surgical Assistants Names Dr. Sidney Funk as Medical Director 2Health News:Scientists design new delivery device for gene therapy 2Health News:Scientists design new delivery device for gene therapy 3Health News:Scientists design new delivery device for gene therapy 4Health News:Eye movements and sight distance reveal how drivers negotiate winding roads 2Health News:Extended use of anti-clotting drug helps some bedridden patients 2Health News:Extended use of anti-clotting drug helps some bedridden patients 3Health News:Shorter Telomere Length Again Linked to Cancer 2Health News:Shorter Telomere Length Again Linked to Cancer 3Health News:Jewelry Collection Announcement: Diamond Dreams Tennis Bracelet Collection 2Health News:Jewelry Collection Announcement: Diamond Dreams Tennis Bracelet Collection 3
... for the screening of factor-V-related APC resistance. ... test for the factor V:Q506 mutation is ... an excess of V-DEF Plasma bioreagent. The ... between heterozygous and homozygous factor V genotypes. ...
Inquire...
Inquire...
... remarkable anti-reflux valve is enclosed ... which prevents the valve from ... in sitting or reclining positions. ... and interference free ensuring uninterrupted ...
Medicine Products: